What: The International Association for the Study of Lung Cancer (IASLC) will host the North America Conference on Lung Cancer Oct. 10-12, 2019, in Chicago, Illinois.
The IASLC North America conference is an educational and scientific event covering key aspects of the diagnosis and management of lung cancer and other thoracic malignancies.
Dr. Douglas R. Lowy, acting director of the National Cancer Institute, will be the featured conference speaker on Friday, Oct. 11. Dr. Lowy collaborated with Dr. John Schiller on the genetic organization of papillomaviruses, identifying the oncogenes encoded by the virus. Their laboratory was involved in the initial development, characterization, and clinical testing of the preventive virus like particle-based HPV vaccines that are now used in three FDA-approved HPV vaccines.
The conference will also provide lectures on accurate diagnosis, including molecular diagnosis, stat-of- the-art treatment of thoracic malignancies, and recent diagnostic and therapeutic advances.
When: October 10-12, 2019
Where: Fairmont Chicago Millennium Park 200 N. Columbus Drive Chicago, IL, USA 60601
Who: healthcare professionals who diagnose and treat patients with lung cancer, medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists, advanced practice nurses, physicians' assistants and media partners will attend for the opportunity to learn and discuss key aspects of the diagnosis and management of lung cancer.
Interview Opportunities: Members of the media will have the opportunity to discuss advancements in lung cancer with physicians and researchers who will be providing panel discussions, clinical trial results and other research developments. Members of the media will also have the opportunity to meet lung cancer survivors and to hear their inspirational stories.
For More Information: Visit NACLC 2019 for more information, including a full schedule of conference events.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit http://www.